Diagnosis and Treatment of Leprosy in Taiwan during the COVID-19 Pandemic: A Retrospective Study in a Tertiaty Center
Open Access
- 13 December 2023
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 13 (24) , 3655
Abstract
Currently, over 200,000 new cases of leprosy are reported annually worldwide. Although leprosy was thought to have been eradicated in Taiwan, a few new cases still occur annually. Protean clinical manifestations of leprosy and immunological reactions result in delayed diagnoses. In addition, drug-resistant leprosy is emerging and poses treatment challenges. In this retrospective study, we collected and analyzed the clinicopathological features, leprosy type, treatment response, and relapse rate of patients with leprosy in our hospital between January 2009 and November 2022. We found that 54% of patients were Indonesian, and borderline lepromatous leprosy was predominant (39%); moreover, histoid leprosy and the Lucio phenomenon were also reported. Polymerase chain reaction analysis identified four positive cases, including a dapsone-resistant (4%) case. Our findings indicated good control of leprosy and a lower rate of dapsone resistance than that reported by the World Health Organization (4% vs. 13%) from 2009 to 2015. We found that the patient profile in terms of the treatment duration, recurrence rate, systemic symptoms, and neurological symptoms did not differ between before and during the pandemic. We report the recent advances in leprosy diagnosis, drug-resistant gene mutations, post-exposure prophylaxis, vaccination, and the effect of coronavirus disease 2019 on leprosy to facilitate updated leprosy diagnosis and management.Keywords
This publication has 49 references indexed in Scilit:
- Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosyRisk Management and Healthcare Policy, 2016
- Minocycline for Recurrent and/or Chronic Erythema Nodosum LeprosumJAMA Dermatology, 2015
- PCR-Based Techniques for Leprosy Diagnosis: From the Laboratory to the ClinicPLOS Neglected Tropical Diseases, 2014
- Application of RLEP Real-Time PCR for Detection of M. leprae DNA in Paraffin-Embedded Skin Biopsy Specimens for Diagnosis of Paucibacillary LeprosyThe American Journal of Tropical Medicine and Hygiene, 2014
- Mutation Analysis of the Mycobacterium leprae folP1 Gene and Dapsone ResistanceAntimicrobial Agents and Chemotherapy, 2011
- Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trialBMJ, 2008
- Response to ciclosporin treatment in Ethiopian and Nepali patients with severe leprosy Type 1 reactionsTransactions of the Royal Society of Tropical Medicine and Hygiene, 2007
- Chemoprophylaxis is Effective in the Prevention of Leprosy in Endemic Countries: a Systematic Review and Meta-AnalysisJournal of Infection, 2000
- The Use of a Specific DNA Probe and Polymerase Chain Reaction for the Detection of Mycobacterium lepraeThe Journal of Infectious Diseases, 1990
- A CLASSIFICATION OF LEPROSY FOR RESEARCH PURPOSESLeprosy Review, 1962